Association Between Psoriasis and Pancreatic Cancer Risk: A Retrospective Cohort Study
Objective: Psoriasis is recognized as a systemic inflammatory condition; however, its association with pancreatic cancer risk remains uncertain. This study aimed to evaluate whether psoriasis is associated with an increased risk of pancreatic cancer. Methods: We conducted a retrospective cohort study using the database from 2006 to 2023 in the TriNetX global federated research network. Patients aged 40–84 years with psoriasis were identified and matched 1:1 to controls without psoriasis using propensity score matching based on demographic and baseline comorbidities. Cumulative incidence, hazard ratios (HRs), and 95% confidence intervals (CIs) were estimated using the TriNetX “Compare Outcomes” module. Results: After 1:1 propensity score matching, each cohort initially comprised 381,381 participants. Following application of 2-year lag period, the final analytic cohorts consisted of 381,032 patients with psoriasis and 381,278 controls. Over a 9-year follow-up period, 516 cases of pancreatic cancer occurred in the psoriasis group and 186 in the control group, corresponding to crude event proportions of 0.135% and 0.049%, respectively. Psoriasis was associated with an increased risk of pancreatic cancer compared with the control group (HR, 2.82; 95% CI, 2.39–3.34). These findings were consistent across multiple sensitivity analyses. Conclusion: Psoriasis is associated with an increased risk of pancreatic cancer in patients aged 40–84 years. Further prospective studies are warranted to validate these findings.
Authors
- Shih‐Wei Lai (ORCID: https://orcid.org/0000-0002-7420-1572)
- Kuan-Fu Liao
Publication Details
- Journal
- Oncology
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1159/ocl/aebag034
- Primary Topic
- Pancreatic and Hepatic Oncology Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00